2024. Bleomycin-induced pulmonary hypertension: an underrated phenomenon with important implications in the setting of high-risk clinical scenarios. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 41, 2 (Jun. 2024), e2024012. DOI:https://doi.org/10.36141/svdld.v41i2.15479.